Vitalhub (TSE:VHI – Get Free Report) announced its quarterly earnings data on Thursday. The company reported C$0.04 earnings per share (EPS) for the quarter, FiscalAI reports. Vitalhub had a return on equity of 2.79% and a net margin of 5.89%. The business had revenue of C$31.91 million during the quarter.
Vitalhub Stock Performance
TSE:VHI opened at C$8.00 on Friday. The firm has a market cap of C$506.71 million, a P/E ratio of 66.67, a P/E/G ratio of 1.18 and a beta of 1.37. Vitalhub has a fifty-two week low of C$6.46 and a fifty-two week high of C$9.81. The firm has a 50-day simple moving average of C$7.58 and a two-hundred day simple moving average of C$7.59.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group set a C$15.00 target price on Vitalhub and gave the stock a “buy” rating in a research note on Friday, August 28th. Six equities research analysts have rated the stock with a Buy rating. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of C$12.67.
Read Our Latest Report on Vitalhub
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Read More
- Five stocks we like better than Vitalhub
- Golden Dome’s $185 Billion Question: Who Actually Gets Paid?
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
